Stock Analysts’ updated eps estimates for Tuesday, August 29th:
Macquarie started coverage on shares of Carter’s (NYSE:CRI). The firm issued an outperform rating and a $100.00 target price on the stock.
Brean Capital assumed coverage on shares of CenterState Banks (NASDAQ:CSFL). Brean Capital issued a hold rating on the stock.
Daimler AG (ETR:DAI) had its neutral rating reiterated by analysts at DZ Bank AG.
Aegis started coverage on shares of DarioHealth Corp. (NASDAQ:DRIO). They issued a buy rating and a $3.50 price target on the stock.
Second Sight Medical Products (NASDAQ:EYES) had its buy rating reiterated by analysts at HC Wainwright. The firm currently has a $5.00 target price on the stock.
Gilead Sciences (NASDAQ:GILD) had its outperform rating reissued by analysts at Credit Suisse Group. The firm currently has a $85.00 price target on the stock, up from their previous price target of $79.00.
Hutchison China MediTech Limited (LON:HCM) had its buy rating reaffirmed by analysts at Panmure Gordon. Panmure Gordon currently has a GBX 3,840 ($49.66) price target on the stock.
Heico Corporation (NYSE:HEI) was upgraded by analysts at Bank of America Corporation from a neutral rating to a buy rating.
Heico Corporation (NYSE:HEI) had its outperform rating reaffirmed by analysts at Credit Suisse Group. The firm currently has a $98.00 target price on the stock, up from their previous target price of $85.00.
Bank of America Corporation started coverage on shares of Helen of Troy Limited (NASDAQ:HELE). Bank of America Corporation issued an underperform rating on the stock.
Juno Therapeutics (NASDAQ:JUNO) was upgraded by analysts at Wedbush from a neutral rating to an outperform rating. They currently have $24.00 price target on the stock, down from their previous price target of $42.00.
Juno Therapeutics (NASDAQ:JUNO) was upgraded by analysts at Raymond James Financial, Inc. to a buy rating. Raymond James Financial, Inc. currently has $45.00 target price on the stock.
Kite Pharma (NASDAQ:KITE) was upgraded by analysts at Wedbush from an underperform rating to a neutral rating.
Benchmark Co. assumed coverage on shares of Mellanox Technologies (NASDAQ:MLNX). The firm issued a buy rating and a $60.00 price target on the stock.
Premier Oil PLC (OTCMKTS:PMOIY) was upgraded by analysts at Jefferies Group LLC from a hold rating to a buy rating.
Stephens initiated coverage on shares of RBB Bancorp (NYSE:RBB). Stephens issued an overweight rating on the stock.
Redhill Biopharma (NASDAQ:RDHL) was upgraded by analysts at Zacks Investment Research from a sell rating to a hold rating. According to Zacks, “Redhill Biopharma Ltd, is an Israel-based specialty biopharmaceutical company. The Company focuses on the development and commercialization of late clinical-stage, proprietary, orally-administered, small molecule drugs for the treatment of gastrointestinal and inflammatory diseases and cancer. It offers the following gastrointestinal products in the United States: Donnatal, a prescription oral adjunctive drug used in the treatment of Irritable Bowel Syndrome (IBS) and acute enterocolitis, as well as EnteraGam, a medical food intended for the dietary management, under medical supervision, of chronic diarrhea and loose stools. Its clinical-stage pipeline includes: TALICIA (RHB-105), an oral combination therapy for the treatment of Helicobacter pylori infection; RHB-104, an oral combination therapy for the treatment of Crohn’s disease; BEKINDA (RHB-102), a once-daily oral pill formulation of ondansetron; RHB-106; YELIVA (ABC294640); MESUPRON, and RIZAPORT (RHB-103). “
Repsol SA (NASDAQ:REPYY) was upgraded by analysts at Zacks Investment Research from a hold rating to a buy rating. They currently have $19.00 price target on the stock. According to Zacks, “Repsol SA explores for, develops and produces crude oil products and natural gas, transports petroleum products and liquified petroleum gas and refines petroleum. In addition, the Company produces a variety of petrochemicals and markets petroleum products, petroleum derivatives, LPG and natural gas. “
RWE AG (FRA:RWE) had its neutral rating reissued by analysts at DZ Bank AG.
Chardan Capital started coverage on shares of Healthways (NASDAQ:TVTY). They issued a neutral rating and a $40.00 price target on the stock.
KLR Group began coverage on shares of Ultra Petroleum Corp (NYSE:UPL). KLR Group issued a buy rating and a $14.00 target price on the stock.
Citigroup Inc. started coverage on shares of Venator Materials PLC (NASDAQ:VNTR). They issued a buy rating on the stock.
